Urology in Medical Technology
Navigation Links
Urology in Medical Technology
... Laparoscopists (AAGL), ETHICON Women's
Health & urology today announced results of a seven-country study ... have used medication ETHICON Women's Health & urology currently is recruiting for two
clinical trials ... Health and Urology
ETHICON Women's Health & urology offers treatment solutions for a range
of common, ...
... products highlight Watson's commitment to urology - Embargoed Until 2:10 PM ... treatments that continually address areas of urology with limited therapeutic options," said Edward ... additions to the expanding Watson urology franchise." In the first trial (abstract ...
... weeks, according to data published in the June issue of The Journal of urology . RAPAFLO(TM) was developed and is manufactured by Watson ... said Leonard S. Marks, MD, author of the study and professor of urology at the Geffen School of Medicine, the University of California at Los ...
... stress urinary incontinence, now available in the January 2009 Journal of urology . This is the first, large, multicenter randomized trial comparing the ... said Gamal Ghoniem, MD, Head, section of Voiding Dysfunction, Female urology and Reconstruction and Chairman of Medical Education at Cleveland Clinic ...
... About ETHICON Women's Health and Urology ETHICON Women's Health & urology offers treatment solutions for a range of common, female pelvic health ... urinary incontinence and pelvic organ prolapse. ETHICON Women's Health & urology is a division of ETHICON, Inc, a Johnson & Johnson company. For more ...
... and businesses. Watson is committed to providing innovative solutions in urology care. With seven products currently available to address conditions ... the symptoms associated with urological conditions, but that helps make urology patients' lives more livable. The Watson portfolio in the U.S. includes ...
... -- Spirus Medical, Inc. ( www.spirusmed.com ), a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, urology and gynecology, announced that physicians using its Endo-Ease(TM) line of devices have performed complete examinations of the small intestine, or ...
... I, Hatzichristou DG, Krane RJ. Impotence and its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study, Journal of urology . Vol. 151, 54-61, January 1994 and World Population Projection Program Of United Nations (2002 Revision) with indirect standardization. (5) ...
... from this landmark study confirm that PROVENGE prolongs survival with a favorable benefit to risk profile," said Paul Schellhammer, MD, professor of urology at Eastern Virginia Medical School / Sentara medical group and a principal investigator of the IMPACT study. "The treatment effect on overall ...
... important milestone and, coupled with the forthcoming launch of GELNIQUE, marks the continued strength and expansion of Watson's Brand Division and urology franchise," said Paul Bisaro, President and Chief Executive Officer of Watson . "We are confident that the proven rapid efficacy and safety of ...
... using localized manual cooling techniques during robotic-assisted radical prostatectomy surgery will be published in the April 2009 issue of urology and is now available online at http://www.goldjournal.net/article/S0090-4295(08)01953-5/abstract . The Hypothermic Nerve-sparing Radical ...
... the Q?CAP(TM), the first and only needle-free reconstitution device, for use with its fertility treatments. Ferring's line of orthopaedic and urology products includes EUFLEXXA(R) (1% sodium hyaluronate) hyaluronic acid for pain from osteoarthritis in the knee and PROSED(R)/DS for the relief of ...
... will begin for the treatment of recurrent prostate cancer in men who have failed external beam radiation therapy. Dr. Herbert Lepor, Chairman of urology at NYU School of Medicine and medical monitor for the trials said, "I have personally reviewed the preliminary data and observed the Sonablate(R) 500 ...
... nation. City of Hope is located in Duarte, Calif., just northeast of Los Angeles, and is ranked as one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more ...
Focal Cryoablation Highlighted in Urology Times Best of AUA Orlando 2008
... as having "low morbidity" in the July issue of urology Times. Focal cryoablation is a ... Association (AUA) in Orlando, the July issue of urology Times captured and summarized key take-home ... the growing acceptance of cryoablation within the urology physician community, Davenport noted. About ...... products highlight Watson's commitment to urology - Embargoed Until 2:10 PM ... treatments that continually address areas of urology with limited therapeutic options," said Edward ... additions to the expanding Watson urology franchise." In the first trial (abstract ...
Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
... those affected," stated Dr. Tim Boone, Chair of urology at The Methodist Hospital in Houston and a member of the Scott Department of urology at Baylor College of Medicine. "Men and women ... Assistant Professor in the Department of urology at Jefferson Medical College of Thomas Jefferson ...... weeks, according to data published in the June issue of The Journal of urology . RAPAFLO(TM) was developed and is manufactured by Watson ... said Leonard S. Marks, MD, author of the study and professor of urology at the Geffen School of Medicine, the University of California at Los ...
... stress urinary incontinence, now available in the January 2009 Journal of urology . This is the first, large, multicenter randomized trial comparing the ... said Gamal Ghoniem, MD, Head, section of Voiding Dysfunction, Female urology and Reconstruction and Chairman of Medical Education at Cleveland Clinic ...
Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial
... be completed by early fall of 2009, is to take place at approximately 20 urology and urogynecology centers across the United States, with total enrollment ... painful bladder syndrome. Dr. Peters is the Chairman of the Department of urology and Director of Clinical Research -- Department of Urology at William ...... About ETHICON Women's Health and Urology ETHICON Women's Health & urology offers treatment solutions for a range of common, female pelvic health ... urinary incontinence and pelvic organ prolapse. ETHICON Women's Health & urology is a division of ETHICON, Inc, a Johnson & Johnson company. For more ...
The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds
... health issues," said Ridwan Shabsigh, M.D., director of the Division of urology at Maimonides Medical Center in Brooklyn, NY and professor of clinical urology at Columbia University. "It's important for men with ED to talk with their ...Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
... Principal Investigators are Ralph Clayman, MD, Chair of the Department of urology at University of California Irvine, and Margaret Pearle, MD, PhD, Professor of urology at University of Texas Southwestern. About Omeros Corporation Omeros ...... and businesses. Watson is committed to providing innovative solutions in urology care. With seven products currently available to address conditions ... the symptoms associated with urological conditions, but that helps make urology patients' lives more livable. The Watson portfolio in the U.S. includes ...
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
... bladder cancer whose cancer is specifically refractory (unresponsive) to current therapy are receiving Urocidin in an open label trial. Thirty-one urology centres in North America are participating in this trial and recruitment of 105 evaluable patients was completed in March, 2009. Data from the ...WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center
... the New Jersey Organ and Tissue Sharing Network. In 2005, he received the National Medical Award for Excellence in Transplantation by the Kidney and urology Foundation of America, Inc. Saint Barnabas Health Care System Renal and Pancreas Transplant Division The Saint Barnabas Renal and Pancreas ...... -- Spirus Medical, Inc. ( www.spirusmed.com ), a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, urology and gynecology, announced that physicians using its Endo-Ease(TM) line of devices have performed complete examinations of the small intestine, or ...
Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research
... Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ; Co-Leader: Peter A. Jones, Ph.D., Distinguished Professor of urology and Biochemistry & Molecular Biology, University of Southern California ; "Targeting the PI3K Pathway in Women's Cancers" / Leader: ...... I, Hatzichristou DG, Krane RJ. Impotence and its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study, Journal of urology . Vol. 151, 54-61, January 1994 and World Population Projection Program Of United Nations (2002 Revision) with indirect standardization. (5) ...
Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis
... - Eight Studies Presented at Leading urology Meeting Show that Simple Urine Test for PCA3 Gene May Improve Accuracy of Prostate Cancer Detection, Reduce Unnecessary Biopsies - - Gen-Probe ...... from this landmark study confirm that PROVENGE prolongs survival with a favorable benefit to risk profile," said Paul Schellhammer, MD, professor of urology at Eastern Virginia Medical School / Sentara medical group and a principal investigator of the IMPACT study. "The treatment effect on overall ...
EAU Position Statement on Screening for Prostate Cancer
... ARNHEM, The Netherlands, April 16 /PRNewswire/ -- The European Association of urology (EAU) has taken into consideration the recent scientific information on randomised screening studies on prostate cancer (Schröder et al, NEJM 2009). ...... important milestone and, coupled with the forthcoming launch of GELNIQUE, marks the continued strength and expansion of Watson's Brand Division and urology franchise," said Paul Bisaro, President and Chief Executive Officer of Watson . "We are confident that the proven rapid efficacy and safety of ...
PSA Screening Cuts Deaths by 20%, Says World's Largest Prostate Cancer Study
... men in seven countries, aged 55-69; only those who had not been screened could take part. The findings are being unveiled at the annual European urology Congress in Stockholm, Sweden (17 - 21 March 2009). By initially screening men 55 to 69 years with the PSA marker and offering regular follow ...New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability
... combination of efficacy and tolerability when utilized to treat symptoms of overactive bladder," said David R. Staskin, MD, associate professor of urology at Tufts University School of Medicine and Caritas - St. Elizabeth's Medical Center and lead author of the study. "GELNIQUE has the potential to be ...FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
... Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate ...... using localized manual cooling techniques during robotic-assisted radical prostatectomy surgery will be published in the April 2009 issue of urology and is now available online at http://www.goldjournal.net/article/S0090-4295(08)01953-5/abstract . The Hypothermic Nerve-sparing Radical ...
Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
... Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate ...Foreign Medical Devices are in High Demand in Russia
... and orthopaedic appliances - Other surgical and medical instruments - Cardiovascular devices - ENT devices - Nephrology and urology devices - Neurology devices - Anesthesia and respiratory devices - Endoscopy devices - Drug delivery devices - In vitro ...Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule
... physician interest and patient acceptance of PTNS therapy at the participating centers," said Dr. Kenneth M. Peters, Chairman of the Department of urology at Beaumont Hospital in Royal Oak, Michigan, and the SUmiT study's principal investigator. "We believe the study's design will deliver to the ...Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
... Inc. is a specialty pharmaceutical company engaged in the acquisition, development, and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate ...... the Q?CAP(TM), the first and only needle-free reconstitution device, for use with its fertility treatments. Ferring's line of orthopaedic and urology products includes EUFLEXXA(R) (1% sodium hyaluronate) hyaluronic acid for pain from osteoarthritis in the knee and PROSED(R)/DS for the relief of ...
Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
... Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate ...Soyfoods Do Not Impact Sperm Count
... every three days. This is not considered a high intake of any food under most circumstances. Dr. Larry Ross, Past President of the American urology Association noted that "Like most epidemiological reports, this study is retrospective and is therefore inherently subject to a variety of biases. ...... will begin for the treatment of recurrent prostate cancer in men who have failed external beam radiation therapy. Dr. Herbert Lepor, Chairman of urology at NYU School of Medicine and medical monitor for the trials said, "I have personally reviewed the preliminary data and observed the Sonablate(R) 500 ...
Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
... frequency and urge incontinence, symptoms often associated with overactive bladder (OAB). Dr. Kenneth M. Peters, Chairman of the Department of urology at Beaumont Hospital in Royal Oak, Michigan, leads the OrBIT (OveRactive Bladder Innovative Therapy) multi-center trial and presented the comparative ...Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
... focus of 17 clinical studies presented at the six-day annual meeting of the American Urological Association (AUA) in Orlando, which is the largest urology meeting of the year. Also, a total of six post-graduate educational courses and workshops related to cryoablation were sponsored by the AUA and, ...Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
... Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) and SANCTURA XR(TM) for overactive bladder, VANTAS(R) for advanced prostate ...FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
... of recurrent prostate cancer with the Sonablate(R) 500 in men who have failed external beam radiation therapy. Dr. Herbert Lepor, Chairman of urology at NYU School of Medicine and medical monitor for the trial said, "It is my pleasure to serve as the medical monitor for the prostate cancer clinical ...... nation. City of Hope is located in Duarte, Calif., just northeast of Los Angeles, and is ranked as one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more ...
Indevus Pharmaceuticals Provides Update on PRO 2000 Program
... Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA XR(TM) and SANCTURA(R) for overactive bladder, VANTAS(R) for advanced prostate ...Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
... Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA XR(TM) and SANCTURA(R) for overactive bladder, VANTAS(R) for advanced prostate ...ORTHO EVRA(R) Prescribing Information Updated
... Inc., is a leader in the fields of women's health and urology, celebrating more than 75 years of partnering with women. Ortho Women's Health & urology is committed to helping people live healthier lives and to meeting the needs of providers and patients with products such as ORTHO TRI-CYCLEN(R) LO ...Other ContentschromatidschromatidssistersistersistersistersistersisterspecificspecificspecificspecificspecificspecificspecificspecificspecificspecificskeletalskeletalskeletalskeletalskeletalskeletalskeletalskeletalskeletalmoldsmoldsmoldsmoldsmoldsmoldsslimeslimeintestineintestineintestineintestineintestineintestinesmallsmallsmallsmallsmallsmallsmallsmallsmallsmallOther TagsKATKATKATKATLaseLaseLaseLaseLaseOther Tagssweet 2sweet 3sweet 4towards 2towards 3towards 4towards 5towards 6towards 7towards 8towards 9towards 10meter 2meter 3later 2later 3later 4later 5later 6later 7later 8later 9later 10
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Grooving down the helix 2Grooving down the helix 3Power Plate 28R 29 Opens Cutting Edge Studio in L A 49383 1Power Plate 28R 29 Opens Cutting Edge Studio in L A 49383 2Benefit of glinides is not proven 49380 1Benefit of glinides is not proven 49380 2Benefit of glinides is not proven 49380 37th annual 5BBC 5D2 Basel Computational Biology Conference Molecular Evolution June 18 19 2009 8899 17th annual 5BBC 5D2 Basel Computational Biology Conference Molecular Evolution June 18 19 2009 8899 27th annual 5BBC 5D2 Basel Computational Biology Conference Molecular Evolution June 18 19 2009 8899 3(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification[0] Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto[0] Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference[0] BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use[0] News brief -- childhood cancer survivor study report: Late recurrence is a risk for some cancers
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |